Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: News Bites Pty Limited
$5.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sun Pharmaceutical Industries Ltd Gets Board Nod To Raise Up To INR8,000 Crore (INR80 Billion)-Business Standard


Wednesday, 3 Oct 2012 12:06pm EDT 

Business Standard reported that Sun Pharmaceutical Industries Ltd said its Board of Directors has approved the proposal to raise up to INR8,000 crore (INR80 billion). The board has approved raising of funds worth up to INR8,000 crore (INR80 billion)through domestic or international offerings. The funds would be raised at an appropriate time through domestic/international offerings including to Indian or foreign institutional investors/foreign mutual funds/overseas corporate bodies/foreigners/other foreign parties/Indian financial institutions/alternative investment funds/qualified institutional buyers/companies/individuals.